|
Top :
New Forum Archives (2009-): :
1. What is the meaning of "1*07:01" in HLA-DRB1*07:01? - (reply: 2)
3. ELISA manufacturer - (reply: 2)
5. IF Two Antigen Retrival Steps - (reply: 3)
7. Are HEK293 cells a positive control for wild type p53 expression? - (reply: 1)
9. Can microglia stain positive for phagocytosed material? - (reply: 2)
11. Methods for enrichment of high binding strength antibodies? - (reply: 3)
13. I can't believe peptide inhibition is a valid epitope mapping method - (reply: 1)
15. Combining alpha and beta TCR chains for sequencing - (reply: 1)
17. Inactivating effects on immune cells caused by mutation in the gene encoding the - (reply: 2)
19. Antibody against E.coli lysate - (reply: 1)
21. Question about ELISA assay - (reply: 5)
23. RBC Antibody Identification - (reply: 2)
25. check immune response - (reply: 1)
27. skin lesion and low donor cell frequency in bone marrow transfer - (reply: 7)
29. Immunosuppression - (reply: 4)
3. ELISA manufacturer - (reply: 2)
5. IF Two Antigen Retrival Steps - (reply: 3)
7. Are HEK293 cells a positive control for wild type p53 expression? - (reply: 1)
9. Can microglia stain positive for phagocytosed material? - (reply: 2)
11. Methods for enrichment of high binding strength antibodies? - (reply: 3)
13. I can't believe peptide inhibition is a valid epitope mapping method - (reply: 1)
15. Combining alpha and beta TCR chains for sequencing - (reply: 1)
17. Inactivating effects on immune cells caused by mutation in the gene encoding the - (reply: 2)
19. Antibody against E.coli lysate - (reply: 1)
21. Question about ELISA assay - (reply: 5)
23. RBC Antibody Identification - (reply: 2)
25. check immune response - (reply: 1)
27. skin lesion and low donor cell frequency in bone marrow transfer - (reply: 7)
29. Immunosuppression - (reply: 4)